Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $18.93M | $0.00 | -$12.55M | -$13.22M | -$0.36 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| KALA | KALA BIO INC | $9.23M | $0.00 | -$29.63M | -$35.65M | -$7.97 | N/A | -100.00% | N/A | N/A | |||
| GOVX | GEOVAX LABS INC | $14.07M | $0.00 | -$24.71M | -$24.81M | -$2.01 | N/A | -100.00% | N/A | N/A | |||
| MRSN | MERSANA THERAPEUTICS INC | $46.11M | $34.77M | -$65.59M | -$74.04M | -$14.62 | 16.14% | 83.02% | N/A | N/A | 2025-11-11 | ||
| FGEN | FIBROGEN INC | $42.66M | -$72.84M | $2.18M | -$2.07M | -$0.38 | N/A | N/A | N/A | N/A | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $3.99M | $0.00 | -$12.97M | -$41.91M | -$66.53 | N/A | N/A | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $94.34M | $0.00 | -$62.26M | -$63.41M | -$0.80 | -100.00% | -100.00% | N/A | N/A | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $78.42M | $0.00 | -$30.97M | -$31.56M | -$3.62 | N/A | N/A | N/A | N/A | |||
| ACXP | ACURX PHARMACEUTICALS INC | $11.85M | $0.00 | -$10.00M | -$10.00M | -$10.69 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| NRXP | NRX PHARMACEUTICALS INC | $62.47M | $0.00 | -$33.79M | -$33.79M | -$2.24 | N/A | N/A | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $202.75M | $81.71M | -$55.42M | -$64.59M | -$0.29 | 565.52% | -6.02% | N/A | N/A | 2025-10-30 | ||
| GRI | GRI BIO INC | $4.68M | $0.00 | -$10.02M | -$11.92M | $3.81 | N/A | N/A | -99.72% | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $69.49M | $5.32M | -$14.57M | -$19.03M | -$2.03 | -3.49% | -3.22% | N/A | N/A | |||
| FEMY | FEMASYS INC | $16.70M | $1.70M | -$18.54M | -$21.11M | -$0.91 | 61.97% | N/A | N/A | N/A | 2025-11-06 | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.97M | $868.00k | -$34.61M | -$50.95M | -$11.94 | -63.88% | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $20.38M | $1.00M | -$20.10M | -$19.31M | -$2.30 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| MDCX | MEDICUS PHARMA LTD | $44.18M | $0.00 | -$16.73M | -$16.51M | -$1.34 | N/A | N/A | N/A | N/A | 2025-11-21 | ||
| MTVA | METAVIA INC | $23.67M | $0.00 | -$18.47M | -$18.49M | -$1.49 | N/A | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $22.25M | $0.00 | -$17.32M | -$17.96M | -$4.10 | N/A | N/A | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $27.44M | $0.00 | -$14.99M | -$13.10M | -$0.58 | N/A | N/A | N/A | N/A | 2025-12-01 | ||
| SKYE | SKYE BIOSCIENCE INC | $53.61M | $0.00 | -$41.90M | -$42.37M | -$1.07 | N/A | N/A | N/A | N/A | |||
| CRDL | CARDIOL THERAPEUTICS INC | $85.98M | $0.00 | -$27.19M | -$27.41M | -$0.34 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $11.13M | $4.17M | -$47.13M | -$50.71M | -$26.46 | -62.68% | N/A | N/A | N/A | |||
| SLN | SILENCE THERAPEUTICS PLC | $235.93M | $27.37M | -$73.76M | -$79.40M | N/A | 21.64% | 73.57% | N/A | N/A | 2025-11-13 | ||
| MBRX | MOLECULIN BIOTECH INC | $14.36M | $0.00 | -$26.43M | -$26.55M | -$3.52 | N/A | N/A | N/A | N/A | |||
| JSPR | JASPER THERAPEUTICS INC | $39.01M | $0.00 | -$88.84M | -$90.92M | -$6.03 | N/A | N/A | N/A | N/A | |||
| NOTE | FISCALNOTE HOLDINGS INC | $66.87M | $109.68M | -$24.45M | -$45.84M | -$3.84 | -15.39% | N/A | N/A | N/A | 2025-11-18 | ||
| ANVS | ANNOVIS BIO INC | $33.13M | $0.00 | -$30.26M | -$30.26M | -$1.99 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| IMUX | IMMUNIC INC | $86.14M | $0.00 | -$96.19M | -$96.40M | -$0.95 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| VNRX | VOLITIONRX LTD | $49.49M | $1.32M | -$21.60M | -$23.32M | -$0.25 | 35.10% | 125.09% | N/A | N/A | 2025-11-13 | ||
| INTS | INTENSITY THERAPEUTICS INC | $14.35M | $0.00 | -$12.55M | -$12.58M | -$0.82 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| MYO | MYOMO INC | $40.83M | $40.76M | -$7.41M | -$9.32M | -$0.22 | 93.07% | 59.13% | N/A | N/A | 2025-11-05 | ||
| PMN | PROMIS NEUROSCIENCES INC | $25.39M | $0.00 | -$8.43M | -$8.43M | -$0.21 | N/A | N/A | N/A | N/A | 2025-11-12 | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $12.90M | $14.65M | -$9.25M | -$11.09M | -$6.64 | -19.32% | 6.35% | N/A | N/A | |||
| PASG | PASSAGE BIO INC | $26.93M | $0.00 | -$55.01M | -$56.86M | -$18.16 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| RNXT | RENOVORX INC | $40.68M | $662.00k | -$11.00M | -$10.66M | -$0.38 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $272.91M | $0.00 | -$223.22M | -$236.91M | -$1.11 | -100.00% | N/A | N/A | N/A | 2025-10-30 | ||
| TIL | INSTIL BIO INC | $129.82M | $0.00 | -$74.48M | -$84.51M | -$12.92 | N/A | N/A | N/A | N/A | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.61M | $0.00 | -$7.09M | -$7.09M | -$3.25 | N/A | N/A | N/A | N/A | |||
| HUMA | HUMACYTE INC | $247.06M | $818.00k | -$40.80M | -$58.66M | -$0.45 | N/A | N/A | N/A | N/A | 2025-11-07 | ||
| BMEA | BIOMEA FUSION INC | $99.97M | $0.00 | -$107.23M | -$112.09M | -$3.02 | N/A | N/A | N/A | N/A | 2025-11-04 | ||
| ACET | ADICET BIO INC | $79.98M | $0.00 | -$107.56M | -$117.32M | -$1.29 | N/A | N/A | N/A | N/A | 2025-11-05 | ||
| CTSO | CYTOSORBENTS CORP | $57.35M | $34.54M | -$13.83M | -$15.84M | -$0.28 | 12.77% | 3.94% | N/A | N/A | 2025-11-06 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.